Risk factors for thrombocytopenia in patients treated with prolonged heparin therapy
Arch Intern Med
.
2008 Oct 27;168(19):2170-1; author reply 2171.
doi: 10.1001/archinte.168.19.2170-b.
Authors
David R Williamson
,
Danielle Pilon
PMID:
18955654
DOI:
10.1001/archinte.168.19.2170-b
No abstract available
Publication types
Comment
Letter
MeSH terms
Anticoagulants / adverse effects
Heparin / adverse effects
Humans
Risk Factors
Thrombocytopenia / etiology*
Substances
Anticoagulants
Heparin